mazzucato20_Robin UtrechtSOPA ImagesLightRocket via Getty Images_covid vaccine

Smart Development

Conceber vacinas para pessoas e não para lucros

Dec 1, 2020 Mariana Mazzucato , Henry Lishi Li, and Els Torreele

LONDRES – Anúncios recentes de uma eficácia demonstrada em ensaios com vacinas contra a COVID-19 trouxeram a esperança de que se avistaria um regresso à normalidade. Os dados preliminares sobre as novas vacinas de mRNA da Pfizer/BioNTech e da Moderna são altamente encorajadores, e sugerem que esteja próxima a sua aprovação para utilização de emergência. E mais notícias recentes de eficácia (se bem que a uma taxa ligeiramente inferior) sobre uma vacina da AstraZeneca e da Universidade de Oxford alimentaram o optimismo de estarem na calha ainda mais avanços.

Em teoria, a chegada de uma vacina segura e eficaz representaria o início do fim da pandemia da COVID-19. Na realidade, nem sequer chegámos ao fim do início de conseguirmos o que é necessário: uma “vacina para as pessoas” que seja distribuída de forma justa e disponibilizada gratuitamente a todos os que dela necessitem.

Na verdade, a tarefa de criar vacinas numa questão de meses merece elogios. A humanidade deu um monumental passo tecnológico em frente. Mas o ponto de partida foram décadas de um imenso investimento público na investigação e no desenvolvimento.

To continue reading, register now.

Subscribe now for unlimited access to everything PS has to offer.

As a registered user, you can enjoy more PS content every month – for free.

Already have an account? Log in

Subscribe to PS Digital

Access every new PS commentary, our entire On Point suite of subscriber-exclusive content – including Longer Reads, Insider Interviews, Big Picture/Big Question, and Say More – and the full PS archive.

Subscribe Now

Mariana Mazzucato

Writing for PS since 2015
53 Commentaries

Mariana Mazzucato, Professor in the Economics of Innovation and Public Value at University College London, is Founding Director of the UCL Institute for Innovation and Public Purpose, Chair of the World Health Organization’s Council on the Economics of Health For All, and a co-chair of the Global Commission on the Economics of Water. She is the author of The Value of Everything: Making and Taking in the Global Economy (Penguin Books, 2019), The Entrepreneurial State: Debunking Public vs. Private Sector Myths (Penguin Books, 2018), Mission Economy: A Moonshot Guide to Changing Capitalism (Penguin Books, 2022), and, most recently, The Big Con: How the Consulting Industry Weakens our Businesses, Infantilizes our Governments and Warps our Economies (Penguin Press, 2023).

Henry Lishi Li

Writing for PS since 2020
1 Commentary

Henry Lishi Li is a research fellow in health innovation at the UCL Institute for Innovation and Public Purpose.

Els Torreele

Writing for PS since 2020
2 Commentaries

Els Torreele is a visiting policy fellow at the UCL Institute for Innovation and Public Purpose.

new comment has been posted. new comments have been posted.

0 Comments on this paragraph, 7 Comments on this article

Rajiv Chopra Dec 8, 2020

The Pfizer vaccine will be useless in 'developing' nations like my own. My understanding is that, even in the West, it will not be easy to roll it out.

I am also a bit worried about the side effects. It seems that we have no choice but to rush the vaccine. However, we will see if there are unforeseen side effects.
A new reply to this comment has been posted.
Robert REYNOLDS Dec 7, 2020

Dear Mariana, Henry and Els,

I hate to be the one to break the news to you but there is never going to be anything that even resembles “the promise of a universal, freely available “people’s vaccine”, while western society operates under a free-market, economic rationalist system with inter alia, its privately owned pharmaceutical industry.

The pharmaceutical industry, like all essential services, operates solely for the purpose of making a profit. Lamentations about the unfairness of business practice conducted in a capitalist economy is rather akin to the brothel owner who complains that the staff are having sex with the clients. It is what will inevitably happen.

I sincerely do not mean to be rude but when you say,

“But for technological advances to translate into Health for All, innovations that are created collectively should be governed in the public interest, not for private profit.”

This to me reflects a high degree of naiveté.

As soon as the whiff of profit is associated with any innovation that is created collectively or otherwise, then the capitalist sharks begin to circle. You immediately hear the platitudinous, disingenuous and self-serving old argument about how ‘efficient’ the private sector is compared with publically owned enterprises.

In your final paragraph you state that, “….there is a better way to do things”. I agree. That ‘better way’ would involve nationalizing the entire pharmaceutical industry and running it in a way that benefits the whole of humanity and not a few greedy shareholders and company executives.
A new reply to this comment has been posted.
Leo Arouet Dec 6, 2020

It is a challenge to bring the public good that vaccines represent to low- and middle-income countries. The usufruct of the vaccines that have been financed with public funds is a contradiction. Thanks for the comment.
A new reply to this comment has been posted.
Sadly No Dec 3, 2020

...
A new reply to this comment has been posted.